This is the authors' abstract. We don't add key points for this paper.
B-cell chronic lymphocytic leukemia is a clinically, genetically and molecularly heterogonous malignancy. 1 During normal B-cell maturation, chromosomal recombination of the immunoglobulin heavy chain V (variable), D (diversity) and J (junctional) gene, and immunoglobulin kappa and lambda light chain V-J gene rearrangement provides the basis for the tremendous immunologic diversity of B cells. 1 Upon encounter with cognate antigen, B cells can undergo a process of somatic hypermutation during the germinal center reaction in which the recombined VDJ acquire point mutations, thus increasing the affinity for the antigen. Patients with unmutated IGHV genes have inferior clinical outcomes when compared with patients with mutated IGHV. 2 , 3 Chromosomal VDJ gene rearrangement is a stochastic, yet highly regulated process. Each B cell undergoes a distinct rearrangement, yielding expression of a unique B cell receptor (BCR). Through the process of allelic exclusion, if the first allelic VDJ rearrangement is productive, VDJ rearrangement does not occur on the second allele. If the first rearrangement is nonproductive, the second allele undergoes VDJ rearrangement to produce a functional BCR. The same principle is followed for light chain rearrangement. The cell undergoes apoptosis if no functional rearrangements are made. Allelic rearrangements can also occur via noncompatible pair of heavy or light chain rearrangement or rescue of deleterious mutations during somatic hypermutation. 4
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Heyman et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: